Registered entities
Arcutis Biotherapeutics, Inc.
Reg. No. 81-2974255United States
Innovation
8 patent families (4 granted) — focus: Human necessities; filing pace slowing. Cited 586 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Social engagement
Social engagement: 32.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include HBM Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 3 | 27% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 2 | 18% |
Recent activity
30 Jun 2026
Product launch
virtual health platform for chronic inflammatory skin diseases
29 Jun 2026
Milestone
regulatory
17 Jun 2026
Event
2026 Revolutionizing Atopic Dermatitis (RAD) conference